Aldeyra Therapeutics's total assets for Q4 2025 were $72.06T, an increase of 92619925.30% from the previous quarter. ALDX total liabilities were $27.81T for the fiscal quarter, a 97382132.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.